Business / Finance

RSS

QualMetrix closes oversubscribed Series A financing round

QualMetrix, Inc., a healthcare analytics company delivering actionable insights to payers, providers, pharma and employers to help them reduce cost while enhancing the quality of healthcare, announced the close of an oversubscribed Series A financing round.

12 Feb 2014

Scientists receive €85 million international drive to develop new and effective drugs

An increasing biological resistance to antibiotics treatment is to be countered by Aston University scientists who will lead a €85 million international drive to develop new and effective drugs.

12 Feb 2014

PAREXEL launches marketing initiative to simplify journey from science to new treatments

As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new marketing initiative that highlights the Company's proven approach to help clients simplify the journey from science to new treatments.

From Parexel 12 Feb 2014

DCR enters into agreement with Pyxant Labs for early clinical trials

DaVita Clinical Research, a specialty contract research organization with services spanning the full spectrum of drug and device development, announced today that it has entered into an agreement through which Pyxant Labs Inc. will provide bioanalytical laboratory services for DCR's early clinical trials.

12 Feb 2014

ADM commits $25 million equity investment in Rennovia

Archer Daniels Midland Company and Rennovia, Inc. announced today that ADM has committed to a $25 million equity investment in the privately held company, which develops catalysts and processes for the cost-advantaged production of chemical products from renewable feedstocks.

11 Feb 2014

QuadraMed strikes strategic partnership with Connected Technology Solutions

QuadraMed Corporation is pleased to announce that it has signed an agreement with Connected Technology Solutions, a leading interactive kiosk design and creative marketing company. As part of the agreement, QuadraMed's intuitive point-of-service patient registration solution, QuadraMed MediKiosk, will run on CTS kiosk technology, offering organizations a proven, cost-effective patient registration and check-in solution.

11 Feb 2014

Theorem Clinical Research forms strategic alliance with Decision Driver Analytics

Theorem Clinical Research has announced the formation of a strategic alliance with Decision Driver Analytics that will integrate health economics and outcomes research (HEOR), predictive modeling and definitive analysis to maximize return on investment for pharmaceutical and medical device research programs.

11 Feb 2014

Ligand Pharmaceuticals' total revenues for Q4 2013 increase 8% to $14.7 million

Ligand Pharmaceuticals Incorporated today reported financial results for the three and 12 months ended December 31, 2013, and provided an operating forecast and program updates.

11 Feb 2014

Zoetis reports revenue of $1.25 billion for Q4 2013

Zoetis Inc. today reported its financial results for the fourth quarter and full year 2013. The company reported revenue of $1.25 billion for the fourth quarter of 2013, an increase of 7% from the fourth quarter of 2012. Revenue reflected an operational increase of 9%, with foreign currency having a negative impact of 2 percentage points.

11 Feb 2014

Mallinckrodt's subsidiary to acquire all outstanding shares of Cadence Pharmaceuticals

Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc.

11 Feb 2014

Cambrex fourth quarter sales increase 46.3% to $103 million

Cambrex Corporation reports results for the fourth quarter and full year ended December 31, 2013.

11 Feb 2014

Cardiome Pharma's subsidiary signs agreement with Tamro to distribute BRINAVESS in Sweden

Cardiome Pharma Corp. today announced that its subsidiary, Correvio GmbH, has entered into an agreement with Tamro AB, headquartered in Gothenburg, Sweden, to distribute BRINAVESS (vernakalant IV) to customers in the Swedish market.

11 Feb 2014

Henry Schein net sales increase 4.9% to $2.5 billion in fourth quarter 2013

Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today reported record financial results for the quarter ended December 28, 2013.

11 Feb 2014

UPS completes acquisition of U.K.-based Polar Speed

UPS today announced it has completed the purchase of U.K.-based Polar Speed, an innovative provider of temperature-sensitive pharmaceutical supply chain solutions in the U.K. The acquisition further strengthens UPS's healthcare network across Europe, providing healthcare companies access to a single source for logistics solutions across the continent.

11 Feb 2014

GenomOncology collaborates with RPCI to develop informatics solution for Next Generation Sequencing

GenomOncology today announced a collaboration with Roswell Park Cancer Institute (RPCI) to develop an informatics solution that enables the association of Next Generation Sequencing results with knowledge resources to define actionable mutations.

11 Feb 2014

Neutra acquires cutting-edge developer of smoke-free nutraceutical delivery systems

Neutra Corp. (OTCBB: NTRR), a fast-growing provider of all-natural wellness solutions, announced today that it acquired Diamond Anvil Designs (DA), a cutting-edge developer of smoke-free nutraceutical delivery systems.

11 Feb 2014

Triple-S announces consolidated revenues of $587.7 and net loss of $1.7 million for Q4 2013

Triple-S Management Corporation (NYSE: GTS), the leading managed care company in Puerto Rico, today announced consolidated revenues of $587.7 million and a consolidated net loss of $1.7 million for the three months ended December 31, 2013.

11 Feb 2014

Denver Health and North Colorado Med Evac announce provider agreement for air-medical transport

Denver Health and North Colorado Med Evac (a Med Trans Corp air medical program) are pleased to announce a contractual preferred provider agreement for air-medical transport and evacuation.

11 Feb 2014

Merck, Samsung Bioepis agree to develop, commercialize MK-1293 for treatment of diabetes

Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon.

10 Feb 2014

Acentia announces acquisition of Business Computer Applications

Acentia, a premier provider of technology and management solutions, today announced it has acquired Atlanta-based Business Computer Applications, Inc., a provider of information technology (IT) services and solutions to the Centers for Disease Control and Prevention and other health agencies.

10 Feb 2014

Business / Finance

QualMetrix closes oversubscribed Series A financing round

Scientists receive €85 million international drive to develop new and effective drugs

PAREXEL launches marketing initiative to simplify journey from science to new treatments

DCR enters into agreement with Pyxant Labs for early clinical trials

ADM commits $25 million equity investment in Rennovia

QuadraMed strikes strategic partnership with Connected Technology Solutions

Theorem Clinical Research forms strategic alliance with Decision Driver Analytics

Ligand Pharmaceuticals' total revenues for Q4 2013 increase 8% to $14.7 million

Zoetis reports revenue of $1.25 billion for Q4 2013

Mallinckrodt's subsidiary to acquire all outstanding shares of Cadence Pharmaceuticals

Cambrex fourth quarter sales increase 46.3% to $103 million

Cardiome Pharma's subsidiary signs agreement with Tamro to distribute BRINAVESS in Sweden

Henry Schein net sales increase 4.9% to $2.5 billion in fourth quarter 2013

UPS completes acquisition of U.K.-based Polar Speed

GenomOncology collaborates with RPCI to develop informatics solution for Next Generation Sequencing

Neutra acquires cutting-edge developer of smoke-free nutraceutical delivery systems

Triple-S announces consolidated revenues of $587.7 and net loss of $1.7 million for Q4 2013

Denver Health and North Colorado Med Evac announce provider agreement for air-medical transport

Merck, Samsung Bioepis agree to develop, commercialize MK-1293 for treatment of diabetes

Acentia announces acquisition of Business Computer Applications

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News